eMed Pharma Group Limited 31/12/2021 iXBRL
eMed Pharma Group Limited 31/12/2021 iXBRL
Company registration number:
09697610
Contents
Statement of financial position
Notes to the financial statements
Statement of financial position
31 December 2021
2021 | 2020 | ||||||||
Note | £ | £ | £ | £ | |||||
Fixed assets | |||||||||
Intangible assets | 4 |
|
|
||||||
_______ | _______ | ||||||||
|
|
||||||||
Current assets | |||||||||
Debtors | 5 |
|
|
||||||
Cash at bank and in hand |
|
|
|||||||
_______ | _______ | ||||||||
|
|
||||||||
Creditors: amounts falling due | |||||||||
within one year | 6 |
(
|
(
|
||||||
_______ | _______ | ||||||||
Net current liabilities |
(
|
(
|
|||||||
_______ | _______ | ||||||||
Total assets less current liabilities |
|
|
|||||||
Creditors: amounts falling due | |||||||||
after more than one year | 7 |
(
|
(
|
||||||
_______ | _______ | ||||||||
Net assets |
|
|
|||||||
_______ | _______ | ||||||||
Capital and reserves | |||||||||
Called up share capital |
|
|
|||||||
Share premium account |
|
|
|||||||
Profit and loss account |
(
|
(
|
|||||||
_______ | _______ | ||||||||
Shareholders funds |
|
|
|||||||
_______ | _______ | ||||||||
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
21 December 2022
, and are signed on behalf of the board by:
Director
Company registration number:
09697610
Notes to the financial statements
Year ended 31 December 2021
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Alexandra House, 43 Alexandra Street, Nottingham, NG5 1AY.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Turnover
Taxation
Intangible assets - development costs and licences
Amortisation
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Impairment
Financial instruments
4.
Intangible assets
Other intangible assets | Total | ||
£ | £ | ||
Cost | |||
At 1 January 2021 |
|
|
|
Additions | 9,710 | 9,710 | |
_______ | _______ | ||
At 31 December 2021 |
|
|
|
_______ | _______ | ||
Amortisation | |||
At 1 January 2021 and 31 December 2021 | - | - | |
_______ | _______ | ||
Carrying amount | |||
At 31 December 2021 |
|
|
|
_______ | _______ | ||
At 31 December 2020 |
|
|
|
_______ | _______ | ||
5.
Debtors
2021 | 2020 | |||
£ | £ | |||
Other debtors |
|
|
||
_______ | _______ | |||
6.
Creditors: amounts falling due within one year
2021 | 2020 | |||
£ | £ | |||
Bank overdraft |
|
|
||
Trade creditors |
|
|
||
Other creditors |
|
|
||
_______ | _______ | |||
|
|
|||
_______ | _______ | |||
7.
Creditors: amounts falling due after more than one year
2021 | 2020 | |||
£ | £ | |||
Other creditors |
|
|
||
_______ | _______ | |||
A loan provider has taken out security by way of a debenture against the value of their funding to the company.
8.
Related party transactions
During the year the company benefited from financing loans from
Mr M Jayanarayan
and Mr P Bergstrom
, both directors of the company.At 31 December 2021 the company owed Mr M Jayanarayan
£nil (2020 - £2,228) and Mr P Bergstrom £3,770 (2020 - £3,770).